Figure 2.KLRB1 in relation to clinical features in BC. (A–D) T stage; (E) Pathological stage; (F) Age; (G) Her2 status; (H–J) The better prognosis related the KLRB1 overexpression.
Figure 2 — Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients | Aging
